Aiming at a particular identification of the predominant cell types and the accordingly conveyed tumor-modulating effects, additional staining analyses of the present EOC patient cohort defined the subset of ACTBL2-positive TILs as CD44-expressing cytotoxic T-cells (CD8 +) and macrophages (CD68 +). The gene discussed is ACTBL2; the disease is neoplasm.